Patient Risk Preference to be Used in Clinical Trial Design

A recent project collaboration between RTI Health Solutions, the Medical Device Innovation Consortium (MDIC) and the Michael J. Fox Foundation for Parkinson’s Research (MJFF) represents the first time patient preferences on benefits and risks have been used as an explicit means to set significance levels in a clinical trial design. Learn more here. (Source: RTI International, 10/18/16)

You might also be interested in:

The Journal of Clinical Pathways Issues Call for Papers 04/16/2021
Acting FDA Commissioner to Share Insight at Medical Device… 04/26/2021
Are Healthcare Prices in the U.S. Too High, Too Low, or Both? 08/25/2020
MDIC Releases Best Practices for Communicating Benefit, Risk,… 09/14/2020
Scientist.com to Acquire HealthEconomics.Com, the World’s… 12/15/2020
6 Recommendations Regarding HTAs in the United States 02/18/2021
Matthew McHugh Appointed Director for Health Outcomes and… 02/10/2021